Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

ContextLogic Stock Keeps Proving Why It Is Not the Next Amazon

By Chris Lau, InvestorPlace Contributor

Revenue fell while losses rose even further as the Wish site failed to captivate customers to spend more on the e-commerce site.

Meta Materials Stock Is Stuck in a Downward Trend and Things Look Bleak

By Chris Lau, InvestorPlace Contributor

Meta Materials is a former meme stock that is unlikely to rebound from buying momentum, after speculators left it.

7 Best Dividend Stocks for a Big, Fat Monthly Income Check

By Chris Lau, InvestorPlace Contributor

These dividend stocks have well-covered payouts and the potential for growth for years to come, exposing investors to diversified holdings.

The Squeeze Is on as Bears Circle Skillz Stock

By Chris Lau, InvestorPlace Contributor

After its dramatic rise and fall, SKLZ stock is at inflection point. It needs a dramatic catalyst in gaming or gambling to move its price.

What to Do After Cassava Sciences Dropped Off a Cliff

By Chris Lau, InvestorPlace Contributor

Cassava Sciences posted positive clinical data but triggered a sell on the news event, as SAVA stock short sellers welcomed the drop.

Load More